drug

glycopyrrolate

1 story · latest Jul 2, 2026

Status: FDA approved Aug 1961 · NDA012827, NDA017558, NDA022571, NDA210997, NDA214919
Brands: Cuvposa, GLYRX-PF, Qbrexza, Robinul, Robinul Forte
Code: NVA237

Relationships

Developed by Hikma Pharmaceuticals

Developed by Fresenius Kabi

Developed by Novartis

Developed by Journey Medical Corp

Also known as

glycopyrronium, glycopyrronium bromide

Timeline

AstraZeneca posts Phase 3 LOGOS, KALOS asthma results; updates Soliris label

Jul 2Weekly roundup, 5 itemsAstraZeneca AZD4045

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.